AR019933A1 - Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica - Google Patents

Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica

Info

Publication number
AR019933A1
AR019933A1 ARP990103523A ARP990103523A AR019933A1 AR 019933 A1 AR019933 A1 AR 019933A1 AR P990103523 A ARP990103523 A AR P990103523A AR P990103523 A ARP990103523 A AR P990103523A AR 019933 A1 AR019933 A1 AR 019933A1
Authority
AR
Argentina
Prior art keywords
polymer
nucleo
granules
covered
procedure
Prior art date
Application number
ARP990103523A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR019933(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR019933A1 publication Critical patent/AR019933A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un gránulo que tiene un nucleo recubierto con un agente antifungico y polímero que comprende: a) un nucleo central, redondeado o esférico que tiene undiámetro de aproximadamente 710 a aproximadamente 1180 microm (malla 16-25); b) una película de recubrimiento de un polímero soluble en agua y de un agenteantifungico; y c) una capa polimérica de revestimiento-sellado, que se caracteriza porque la concentracion residual de diclorometano en dicho gránulo es demenos de 600 ppm.
ARP990103523A 1998-07-17 1999-07-16 Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica AR019933A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202408 1998-07-17

Publications (1)

Publication Number Publication Date
AR019933A1 true AR019933A1 (es) 2002-03-27

Family

ID=8233945

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103523A AR019933A1 (es) 1998-07-17 1999-07-16 Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica

Country Status (21)

Country Link
US (3) US6663901B1 (es)
EP (1) EP1104291B1 (es)
JP (1) JP2002520351A (es)
KR (1) KR100549095B1 (es)
AR (1) AR019933A1 (es)
AT (1) ATE303798T1 (es)
AU (1) AU766041B2 (es)
BR (1) BR9906712A (es)
CA (1) CA2315110C (es)
DE (1) DE69927163T2 (es)
DK (1) DK1104291T3 (es)
ES (1) ES2249904T3 (es)
ID (1) ID27549A (es)
IL (1) IL137665A0 (es)
MY (1) MY122469A (es)
NZ (1) NZ505245A (es)
RU (1) RU2219909C2 (es)
SI (1) SI1104291T1 (es)
TR (1) TR200002217T2 (es)
TW (1) TWI240639B (es)
WO (1) WO2000003697A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1104291B1 (en) * 1998-07-17 2005-09-07 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
BR0116377A (pt) * 2000-12-22 2005-12-13 Baxter Int Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1842532A3 (en) * 2001-02-06 2009-04-22 Stiefel Laboratories, Inc. Oral sparingly water-soluble antifungal formulations and methods of making the same
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
WO2004012714A1 (en) * 2002-08-05 2004-02-12 Dsm Ip Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
ATE357235T1 (de) † 2003-01-14 2007-04-15 Cimex Pharma Ag Bioaequivalente zusammensetzung in der form einer festen dispersion enthaltend itraconazol und ein hydrophiles polymer
DK1438960T4 (da) * 2003-01-14 2013-03-25 Cimex Pharma Ag Sammensætning af itraconazol dispergeret i en hydrofil polymer med forhøjet biotilgængelighed
US20050244568A1 (en) * 2004-03-04 2005-11-03 Sorsus Gmbh Artificial fruit
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
US20070148240A1 (en) * 2005-12-23 2007-06-28 Fang-Yu Lee Oral formulation containing itraconazole and methods for manufacturing and using the same
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
WO2008068299A2 (en) 2006-12-06 2008-06-12 Tibotec Pharmaceuticals Ltd. Hydrobromide salt of an anti-hiv compound
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
AU2008318851B2 (en) * 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
CA2716642C (en) * 2008-03-28 2017-02-28 Boehringer Ingelheim International Gmbh Method for manufacturing acid pellets
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2941081B2 (ja) * 1991-03-26 1999-08-25 株式会社奈良機械製作所 結晶性有機化合物の非晶質割合の増加と再結晶化を抑制する方法
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
AU731704B2 (en) * 1996-06-28 2001-04-05 Schering Corporation Oral composition comprising a triazole antifungal compound
ATE241969T1 (de) * 1997-03-26 2003-06-15 Janssen Pharmaceutica Nv Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
EP1104291B1 (en) * 1998-07-17 2005-09-07 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer

Also Published As

Publication number Publication date
AU5037499A (en) 2000-02-07
JP2002520351A (ja) 2002-07-09
TWI240639B (en) 2005-10-01
CA2315110A1 (en) 2000-01-27
IL137665A0 (en) 2001-10-31
ES2249904T3 (es) 2006-04-01
US6663901B1 (en) 2003-12-16
US20050142188A1 (en) 2005-06-30
SI1104291T1 (sl) 2006-02-28
WO2000003697A1 (en) 2000-01-27
ATE303798T1 (de) 2005-09-15
EP1104291A1 (en) 2001-06-06
US20040081696A1 (en) 2004-04-29
BR9906712A (pt) 2000-10-10
AU766041B2 (en) 2003-10-09
DE69927163T2 (de) 2006-06-29
ID27549A (id) 2001-04-12
EP1104291B1 (en) 2005-09-07
RU2219909C2 (ru) 2003-12-27
KR100549095B1 (ko) 2006-02-06
TR200002217T2 (tr) 2001-02-21
KR20010015888A (ko) 2001-02-26
CA2315110C (en) 2006-09-12
DE69927163D1 (de) 2005-10-13
DK1104291T3 (da) 2006-01-16
MY122469A (en) 2006-04-29
NZ505245A (en) 2001-12-21

Similar Documents

Publication Publication Date Title
AR019933A1 (es) Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
KR890007720A (ko) 조절 방출성 용량 형태
PT1140012E (pt) Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
KR910016320A (ko) 가교결합된 중합체 상에 지지되고 중합체 필름으로 피복된 약제의 방출이 조절되는 치료학적 조성물 및 이의 제조방법
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
EP1413327A4 (en) STENT
DE69917866D1 (de) Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
KR910004180A (ko) 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
ATE322819T1 (de) Biozides puder mit verzögerter freisetzung
ATE234079T1 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
ATE79029T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe.
ES2173930T3 (es) Articulos expandidos de material plastico biodegradable y un proceso para la preparacion de los mismos.
KR920700617A (ko) 투약 장치
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
PA8458101A1 (es) Formas de dosificacion farmaceuticas solidas
ES2134991T3 (es) Agentes pesticidas.
DE69812182D1 (de) Kollisionsbeständiger behälter enthaltend eine schicht eines polyoxymethylen-polymers
WO2002024174A3 (en) Sustained release composition containing clarithromycin
DE69832807D1 (de) Reinigungsmittel für harte oberflächen, enthaltend hydrophiles, scherkraft-verdünnendes polymer in sehr geringer menge
DE60114629D1 (de) Partikel zur anwendung in einem trockenen produkt oder artikel
ES2146064T3 (es) Metodo de producir un producto repelente del agua, y producto y metodo para impermeabilizar una superficie de un material de construccion.
BR9909963A (pt) Péletes possuindo um núcleo revestido com um agente redutor de lipìdeos e um polìmero

Legal Events

Date Code Title Description
FB Suspension of granting procedure